**Core Concept:** Ewing's sarcoma is a malignant bone tumor that belongs to the group of PNET (Primitive Neuroectodermal Tumors). It develops primarily in the diaphysis of long bones and is often treated with a combination of radiotherapy, chemotherapy, and surgery. The treatment approach aims to improve survival rates and reduce complications.

**Why the Correct Answer is Right:**
In this question, we are asked to identify a poor prognostic factor in Ewing's sarcoma. A poor prognostic factor is a characteristic or condition that negatively influences the patient's outcome, such as survival or response to treatment. In the case of Ewing's sarcoma, the primary treatment methods are radiotherapy, chemotherapy, and surgery.

**Why Each Wrong Option is Incorrect:**
A. **Option A (Radiotherapy):** Radiotherapy is a standard treatment modality for Ewing's sarcoma and is aimed at destroying cancer cells while minimizing damage to surrounding healthy tissues. While radiotherapy may not be as effective as chemotherapy in some cases, it is not considered a poor prognostic factor.

B. **Option B (Large tumor size):** Although larger tumors may indicate more advanced disease, tumor size alone is not universally recognized as a poor prognostic factor for Ewing's sarcoma. Other factors, such as age, disease extent, and the presence of pulmonary or axial involvement, are more influential in determining prognosis.

C. **Option C (Younger age):** While younger patients may have a higher risk of disease progression and may require more intensive treatment regimens, age itself is not universally considered a poor prognostic factor for Ewing's sarcoma.

D. **Option D (Pulmonary or axial involvement):** The presence of pulmonary or axial involvement (e.g., involvement of the axial skeleton or lungs) is a poor prognostic factor in Ewing's sarcoma, as it indicates a higher risk of disease progression and distant spread. These factors contribute to a worse prognosis and may require more aggressive treatment regimens.

**Clinical Pearl:** Understanding the factors that can negatively impact prognosis in Ewing's sarcoma is essential for tailoring treatment plans and discussing the potential risks and benefits with patients and their families. Involvement of the lungs or axial skeleton (CNS, spine, etc.) is a crucial factor to consider when determining treatment intensity and discussing prognosis with patients and their families. While age, tumor size, and radiation therapy are also important factors to consider, they are not as universally recognized as poor prognostic indicators compared to pulmonary or axial involvement.